Xenon Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone, to the 44th Annual J.P. Morgan Healthcare Conference. My name is Tessa Romero, and I'm one of the senior biotech analysts here at J.P. Morgan. Our next presenting company is Xenon Pharmaceuticals.
And presenting on behalf of the company, we have President and CEO, Ian Mortimer. Ian, over to you.
Thank you, Tess. Good morning, everyone. Great to be here, kick off the year at J.P. Morgan and a really big update for Xenon. It's been a very important and impressive year over the last 12 months.
And now we're right on the doorstep of our first Phase III clinical data. So we'll go through that today. I'm joined by some of my colleagues here. To my immediate left, Chris Kenney, our Chief Medical Officer; and to his left, Darren Cline, our Chief Commercial Officer; and Tucker Kelly, our CFO, is here as well.
Tucker and Darren are newer members of the team
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
